Thus triple negative breast cancer patients who are difficult to treat with hormone therapy might be treated with a combination of anti-VEGF therapy and metformin, which collectively could reduce the burden of these tyrosine kinases. Here, VEGFA is linked to triple-negative breast carcinoma.